相关实验视频
Updated: Jul 19, 2025

08:40
Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
7.2K
在炎症性肠道疾病中贫血的患病率和危险因素:一个病例对照研究
Tahir Aslam1, Asim Mehmood2,3
1Internal Medicine, Hayatabad Medical Complex Peshawar, Peshawar, PAK.
Cureus
|August 18, 2023
概括
贫血常见于炎症性肠病 (IBD),影响患者的健康. 治疗方法因贫血类型而异,有针对性的铁补充剂和慢性疾病管理对于有效的护理和改善结果至关重要.
科学领域:
- 胃肠病学 胃肠病学
- 血液学 血液学 血液学
- 内部医学 内部医学
背景情况:
- 炎症性肠道疾病 (IBD),包括克罗恩病和性结肠炎,经常与贫血有关,影响25%至75%的患者.
- IBD患者的贫血会显著损害健康和生活质量,需要有效的管理策略.
- 了解IBD中贫血的细微差别对于优化患者护理和治疗疗效至关重要.
研究的目的:
- 在被诊断为IBD的患者中调查贫血治疗的有效性和安全性.
- 为了比较贫血和非贫血IBD患者队列之间的特征和治疗反应.
- 确定IBD群体内贫血类型的差异及其管理影响.
主要方法:
- 采用病例控制研究设计,将60名贫血IBD患者 (病例) 与60名非贫血IBD患者 (对照) 进行比较.
- 数据收集涉及患者采访,医疗记录审查和实验室测试报告.
- 使用SPSS 23.0版本进行统计分析,以比较人口,临床和实验室参数.
主要成果:
- 贫血IBD患者 (病例) 年龄较大,女性比例较高,收入低于对照组.
- 病例的平均血红蛋白和铁水平显著降低 (分别为p = 0.042和p = 0.009).
- 贫血与克罗恩氏病活动指数和梅奥得分的增加有关,并且观察到不同的贫血类型 (缺铁与慢性疾病).
结论:
- IBD患者经常出现低血红蛋白和铁水平,表明贫血,这可能与疾病活性相关.
- 治疗反应和副作用 (胃肠道问题,过敏,铁过载) 根据贫血类型和铁替代史不同.
- 个性化的贫血治疗策略,包括针对缺铁贫血的向补充剂和慢性疾病因素的管理,对于IBD患者至关重要.
相关概念视频
Inflammatory Bowel Disease I: Ulcerative Colitis
215
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
215
Inflammatory Bowel Disease II: Crohn's Disease
290
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
290
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
355
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
355
Chronic Bowel Disorders: Introduction
485
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
485
Irritable Bowel Syndrome I: Introduction
313
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
313
Inflammatory Bowel Disease IV: Pharmacological Management
152
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
152

